Posts With Tag XORTX Therapeutics

Showing 1 - 3 of 3 Posts

XORTX Therapeutics Inc. Files February 2025 Form 6-K: Key Insights & Updates

$XRTX

•

Form 6-K

•

2025-02-24

Last updated: 2 months ago

XORTX Therapeutics Inc. Files February 2025 Form 6-K: Key Insights & Updates

Explore XORTX Therapeutics' February 2025 Form 6-K filing, highlighting regulatory compliance, executive insights, and a significant press release.

XORTX Therapeutics biotechnology SEC filings foreign private issuer financial compliance

XORTX Therapeutics Inc. Form 6-K Filing: Key Updates for January 2025

$XRTX

•

Form 6-K

•

2025-01-06

Last updated: 4 months ago

XORTX Therapeutics Inc. Form 6-K Filing: Key Updates for January 2025

Explore XORTX Therapeutics Inc.'s Form 6-K filing, dated January 6, 2025, detailing compliance, CEO signature, and press release highlights.

XORTX Therapeutics biotechnology SEC filings Form 6-K Calgary

XORTX Therapeutics Inc. 6-K Report: Key Financials & Updates (Dec 2024)

$XRTX

•

Form 6-K

•

2024-12-19

Last updated: 5 months ago

XORTX Therapeutics Inc. 6-K Report: Key Financials & Updates (Dec 2024)

Discover XORTX Therapeutics Inc.'s latest Form 6-K filing, revealing crucial financial insights and updates as of December 19, 2024. Explore the attached press release for more.

XORTX Therapeutics biotechnology financial reporting Form 6-K SEC filings